Vladimir Zelman Center for Neurobiology and Brain Rehabilitation and Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow 143025, Russia.
Koltzov Institute of Developmental Biology of Russian Academy of Sciences, 26 Vavilov Street, Moscow 119334, Russia.
Cells. 2022 Aug 11;11(16):2498. doi: 10.3390/cells11162498.
Autologous macrophage transfer is an emerging platform for cell therapy. It is anticipated that conventional macrophage reprogramming based on ex vivo polarization using cytokines and ligands of TLRs may enhance the therapeutic effect. We describe an alternative approach based on small interfering RNA (siRNA) knockdown of selected molecular cues of macrophage polarization, namely EGR2, IRF3, IRF5, and TLR4 in Raw264.7 monocyte/macrophage cell line and mouse-bone-marrow-derived macrophages (BMDMs). The impact of IRF5 knockdown was most pronounced, curtailing the expression of other inflammatory mediators such as IL-6 and NOS2, especially in M1-polarized macrophages. Contrary to IRF5, EGR2 knockdown potentiated M1-associated markers while altogether abolishing M2 marker expression, which is indicative of the principal role of EGR2 in the maintenance of alternative phenotypes. IRF3 knockdown suppressed M1 polarization but upregulated Arg 1, a canonical marker of alternative polarization in M1 macrophages. As anticipated, the knockdown of TLR4 also attenuated the M1 phenotype but, akin to IRF3, significantly induced Arginase 1 in M0 and M1, driving the phenotype towards M2. This study validates RNAi as a viable option for the alteration and maintenance of macrophage phenotypes.
自体巨噬细胞转移是细胞治疗的一个新兴平台。预计基于细胞因子和 TLR 配体的体外极化对传统巨噬细胞进行重编程可能会增强治疗效果。我们描述了一种替代方法,即使用小干扰 RNA(siRNA)敲低巨噬细胞极化的选定分子线索,即在 Raw264.7 单核细胞/巨噬细胞系和小鼠骨髓来源的巨噬细胞(BMDM)中敲低 EGR2、IRF3、IRF5 和 TLR4。IRF5 敲低的影响最为显著,抑制了其他炎症介质的表达,如 IL-6 和 NOS2,特别是在 M1 极化的巨噬细胞中。与 IRF5 相反,EGR2 敲低增强了与 M1 相关的标志物,同时完全消除了 M2 标志物的表达,这表明 EGR2 在维持替代表型中起着主要作用。IRF3 敲低抑制了 M1 极化,但上调了 Arg1,这是 M1 巨噬细胞中替代极化的典型标志物。如预期的那样,TLR4 的敲低也减弱了 M1 表型,但与 IRF3 类似,在 M0 和 M1 中显著诱导了精氨酸酶 1,使表型向 M2 方向发展。本研究验证了 RNAi 作为改变和维持巨噬细胞表型的可行选择。